Intra-Cellular Therapies Inc (NASDAQ:ITCI)

19.30
BATS BZX Real-Time Price
As of 12:50pm ET
 -0.16 / -0.82%
Today’s Change
7.85
Today|||52-Week Range
25.82
+33.29%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close19.46
Today’s open19.32
Day’s range18.89 - 19.38
Volume9,506
Average volume (3 months)520,359
Market cap$1.3B
Data as of 12:50pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+21.19%
Earnings growth (this year)-57.43%
Earnings growth (next 5 years)--
Revenue growth (last year)-25.66%
P/E ratioNM
Price/Sales2,720.15
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...+0.01+0.14%
ACHNAchillion Pharmaceut...+0.06+1.65%
SGYPSynergy Pharmaceutic...0.000.00%
PRTKParatek Pharmaceutic...-0.32-2.90%
Data as of 12:51pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$245.8K
Annual profit (last year)-$97.8M
Net profit margin-39,771.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts